Skip to content

Clinical trials

Wet Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wet Macular Degeneration Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20091
20102
20115
20127
20133
201410
20154
20163
20175
20185
201911
20209
202110
20227
20232
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Active, not recruiting9
Recruiting8
Unknown status8
Terminated6
Withdrawn2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Bayer8
Outlook Therapeutics, Inc.5
AbbVie4
4D Molecular Therapeutics3
Adverum Biotechnologies, Inc.3
Boehringer Ingelheim2
Centre Hospitalier Intercommunal Creteil2
EyeBiotech Ltd.2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wet Macular Degeneration93
Macular Degeneration55
Eye Diseases18
Vision Disorders17
Choroidal Neovascularization16
Geographic Atrophy15
Retinal Diseases15
Retinal Degeneration13
Retinal Vein Occlusion8
Blindness5

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.